Tracking the COVID-19 vaccines: The global landscape

202370 citationsReviewgold Open Access

Authors

Tushar Yadav · Jawaharlal Nehru Medical College

Swatantra Kumar · King George's Medical University

Gourav Mishra · Institute of Engineering

Shailendra K. Saxena · King George's Medical University

Abstract

COVID-19: Coronavirus disease 2019; SARS-CoV-2: Severe acute respiratory syndrome coronavirus-2; VLPs: Virus like particles; WHO: World Health Organization; E: Envelope; M: Membrane; S: Spike; N: Nucleocapsid; PRISMA: Preferred Reporting Items for Systematic Reviews and Meta-Analyses; FDA: Food and Drug Administration; LNP: lipid-nanoparticle; AZD1222: ChAdOx1 nCoV-19; BNT162b2: Pfizer-BioNTech mRNA vaccine; mRNA-1273: Moderna vaccine; Ad26.COV2.S: Johnson and Johnson - Janssen's vaccine; Gam-COVID-Vac: Sputnik Vaccine; NVX-CoV2373: Novavax vaccine with Matrix-M™ adjuvant.

Topics & Keywords

SARS-CoV-2 and COVID-19 Research Vaccine Coverage and Hesitancy COVID-19 Clinical Research Studies

UN Sustainable Development Goals

Good health and well-being

Publication Details

Published in: Human Vaccines & Immunotherapeutics

Volume 19, Issue 1, pp. 2191577-2191577

DOI: 10.1080/21645515.2023.2191577

Field-Weighted Citation Impact: 13.63